CA88ÐÔÃü¿ÆѧѧԺÐÄѪ¹Ü×êÑÐËù±´Òãèë½ÌÊÚÔÚCirculation Research °ä·¢ÂÛÎÄ

½üÈÕ£¬CA88ÐÔÃü¿ÆѧѧԺÐÄѪ¹Ü×êÑÐËù±´Òãèë½ÌÊÚÔÚCirculationResearch(IF=20.1)ÔÓÖ¾ÔÚÏß°ä·¢ÁËÌâΪ¡°Exercise Inhibits Doxorubicin-Induced Cardiotoxicity via Regulating B Cells¡±µÄ×îÐÂ×êÑгɾͣ¨https://www.ahajournals.org/doi/abs/10.1161/CIRCRESAHA.123.323346?id=fig0£©¡£¸Ã×êÑз¢ÏֻѵÁ·Í¨¹ýµ÷¿ØBϸ°û±í±íÊÜÌåFC¦ÃRIIBµÄ±í°×£¬¼õÇᰢùËØÓÕµ¼µÄÐÄÔ඾ÐÔ£¨Í¼1£©¡£±´Òãèë½ÌÊÚºÍФºÃºº½ÌÊÚΪ¹²Í¬Í¨Ñ¶×÷Õß£¬Íõ¾²¸±½ÌÊÚ¡¢²©Ê¿ÉúÁõÊéÇÙºÍ˶ʿÉúÃÏÐÂÐãΪ¹²Í¬µÚÒ»×÷Õß£¬CA88ΪµÚһʵÏÖµ¥Ôª¡£

ͼ1

°¢Ã¹ËØ£¨Dox£©×÷ΪһÖÖÓÐЧµÄ»¯ÁÆÒ©Îï£¬ÆäÓÃÒ©¹ý³ÌʱʱÒýÆð¼±ÐÔºÍÂýÐÔÐÄÔ඾ÐÔ£¬²¢°éÓÐÑϳÁµÄÐÄÔàÑ×Ö¢¡£»î¶¯ÑµÁ·Äܹ»ÒÖÔìDoxÒýÆðµÄÐÄÔ඾ÐÔ£¬È»¶ø£¬ÃâÒßϸ°ûÊÇ·ñ²Î¼Ó»î¶¯µÄ±
£»¤×÷ÓÃÉÐδÃ÷È·¡£¸Ã×êÑз¢ÏֻÄܹ»ÓÐЧ½µµÍBϸ°û²úÉúµÄÑ×Ö¢Òò×ӺͿ¹Ìåˮƽ£¬²¢ÇÒÓÐЧ±
£»¤DoxÓÕµ¼µÄÐÄÔ඾ÐÔ¡£FC¦ÃRIIB×÷ΪһÖÖ³ÁÒªµÄBϸ°û»î»¯½éÖÊ£¬ÄܶԻѵÁ·×ö³ö·´Ó³£¬²¢µ÷¿ØBϸ°û²Î¼Ó»î¶¯¼õÇáDoxÓÕµ¼ÐÄÔ඾ÐԵı
£»¤×÷Ó᣻ͨ¹ýÉϵ÷Bϸ°ûFC¦ÃRIIBµÄ±í°×£¬Ìá¸ßBϸ°û»î»¯ãÐÖµ£¬½µµÍBϸ°û»î»¯Ë®Æ½£¬½ø¶øÒÖÔìÐÄÔàÑ×Ö¢¼°Ðļ¡Î£ÏÕ£¬¼õÇáDoxÓÕµ¼µÄÐÄÔ඾ÐÔ¡£

CirculationResearchÔÓ־רÃÅΪ¸Ã×êÑÐ׫дÉçÂÛ£¨Í¼2£©£¬Ö¸³ö£º¡°B-cell checkpoints is currently heralded as a potential novel treatment of cancer and autoimmune disease. Wang and colleagues¡¯ work suggests a role for B-cell inhibitory receptors like Fc¦ÃRIIB in cardiac-immune cross talk.¡±(https://www.ahajournals.org/doi/10.1161/CIRCRESAHA.124.324243?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed)

¸Ã×êÑй¤×÷µÃµ½Á˹ú¶ÈÌìÈ»¿Æѧ»ù½ð¡¢ÉϺ£ÊпÆί¡¢ÉϺ£ÊнÌίµÈÏîÖ÷ÕÅ´óÁ¦ÔÞÖúºÍÖ§³Ö¡£ºÉÀ¼ÎÚµÃÀÕÖ§´óѧ¡¢¹þ·ð´óѧµÈ×êÑÐÕßÒ²²Î¼ÓÁ˸Ã×êÑС£

ͼ2

×ÛÉÏËùÊö£¬FC¦ÃRIIB×÷ΪһÖÖ³ÁÒªµÄBϸ°û»î»¯½éÖÊ£¬»î¶¯ÑµÁ·Äܹ»½µµÍFC¦ÃRIIBµÄ±í°×£¬²¢µ÷¿ØBϸ°û²Î¼Ó»î¶¯¼õÇáDoxÓÕµ¼ÐÄÔ඾ÐԵı
£»¤×÷ÓÃ£¬¸Ã×êÑÐÓÐÍûΪÐÄÔàÃâÒßÒ½ÖÎÌṩаеã¡£